These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12959321)

  • 1. Absence of an inhibitory effect of omeprazole and nizatidine on phenytoin disposition, a marker of CYP2C activity.
    Bachmann KA; Sullivan TJ; Jauregui L; Reese JH; Miller K; Levine L
    Br J Clin Pharmacol; 1993 Oct; 36(4):380-2. PubMed ID: 12959321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of pharmacokinetic interaction between lansoprazole and intravenously administered phenytoin.
    Karol MD; Locke CS; Cavanaugh JH
    J Clin Pharmacol; 1999 Dec; 39(12):1283-9. PubMed ID: 10586395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions of H2-receptor antagonists.
    Bachmann KA; Sullivan TJ; Jauregui L; Reese J; Miller K; Levine L
    Scand J Gastroenterol Suppl; 1994; 206():14-9. PubMed ID: 7863246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole.
    Furuta S; Kamada E; Suzuki T; Sugimoto T; Kawabata Y; Shinozaki Y; Sano H
    Xenobiotica; 2001 Jan; 31(1):1-10. PubMed ID: 11334262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum phenytoin concentrations associated with coadministration of sertraline.
    Haselberger MB; Freedman LS; Tolbert S
    J Clin Psychopharmacol; 1997 Apr; 17(2):107-9. PubMed ID: 10950473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the Pharmacokinetics of Phenytoin in Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.
    Kusunoki Y; Kido Y; Naito Y; Kon R; Mizukami N; Kaneko M; Wakui N; Machida Y; Ikarashi N
    Int J Toxicol; 2017; 36(6):485-491. PubMed ID: 29130833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation.
    Lemahieu WP; Maes BD; Verbeke K; Vanrenterghem Y
    Kidney Int; 2005 Mar; 67(3):1152-60. PubMed ID: 15698457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers.
    Dixit RK; Chawla AB; Kumar N; Garg SK
    Methods Find Exp Clin Pharmacol; 2001; 23(1):37-9. PubMed ID: 11413862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin.
    Böttiger Y; Tybring G; Götharson E; Bertilsson L
    Clin Pharmacol Ther; 1997 Oct; 62(4):384-91. PubMed ID: 9357389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of menthol on the pharmacokinetics of triazolam and phenytoin.
    Hoshino M; Ikarashi N; Hirobe R; Hayashi M; Hiraoka H; Yokobori K; Ochiai T; Kusunoki Y; Kon R; Tajima M; Ochiai W; Sugiyama K
    Biol Pharm Bull; 2015; 38(3):454-60. PubMed ID: 25757928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats.
    Konishi H; Yoshimoto T; Morita K; Minouchi T; Sato T; Yamaji A
    J Pharm Pharmacol; 2003 Jan; 55(1):143-9. PubMed ID: 12625878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.
    Odani A; Hashimoto Y; Otsuki Y; Uwai Y; Hattori H; Furusho K; Inui K
    Clin Pharmacol Ther; 1997 Sep; 62(3):287-92. PubMed ID: 9333104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral phenytoin pharmacokinetics during omeprazole therapy.
    Prichard PJ; Walt RP; Kitchingman GK; Somerville KW; Langman MJ; Williams J; Richens A
    Br J Clin Pharmacol; 1987 Oct; 24(4):543-5. PubMed ID: 3689634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose omeprazole on plasma bupivacaine concentrations following epidural administration.
    Dowd NP; Taylor A; Moriarty DC; Blunnie WP
    Can J Anaesth; 1997 Sep; 44(9):1029. PubMed ID: 9305572
    [No Abstract]   [Full Text] [Related]  

  • 15. P450 2C18 catalyzes the metabolic bioactivation of phenytoin.
    Kinobe RT; Parkinson OT; Mitchell DJ; Gillam EM
    Chem Res Toxicol; 2005 Dec; 18(12):1868-75. PubMed ID: 16359177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole fails to alter the cytochrome P450-dependent 2-hydroxylation of estradiol in male volunteers.
    Galbraith RA; Michnovicz JJ
    Pharmacology; 1993 Jul; 47(1):8-12. PubMed ID: 8337235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No influence of pantoprazole on the pharmacokinetics of phenytoin.
    Middle MV; Müller FO; Schall R; Groenewoud G; Hundt HK; Huber R; Bliesath H; Steinijans VW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S72-5. PubMed ID: 8793606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.
    Coruzzi G; Coppelli G; Frati P; Bertaccini G
    Pharmacol Res; 1998 Dec; 38(6):469-73. PubMed ID: 9990656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions between erythromycin, clarithromycin, roxithromycin and phenytoin in the rat.
    al-Humayyd MS
    Chemotherapy; 1997; 43(2):77-85. PubMed ID: 9084915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the interaction between omeprazole and phenytoin in epileptic patients.
    Andersson T; Lagerström PO; Unge P
    Ther Drug Monit; 1990 Jul; 12(4):329-33. PubMed ID: 2396305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.